Glass House Brands (GLAS) Asset Writedowns and Impairment (2022 - 2026)

Glass House Brands' (GLAS) quarterly Asset Writedowns and Impairment came in at -$128000.0 in Q1 2026, up 76.68% on a QoQ basis from -$549000.0 in Q4 2025.

Glass House Brands (GLAS) Asset Writedowns and Impairment (2022 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 5 years of Asset Writedowns and Impairment data on file, last reported at -$128000.0 in Q1 2026.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to -$128000.0 in Q1 2026; TTM through Mar 2026 was -$522000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $1.4 million, down 78.56% from the prior year.
  • Asset Writedowns and Impairment for Q1 2026 stood at -$128000.0, up from -$549000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for GLAS reached as high as $1328.4 billion in Q2 2023 and fell as low as -$549000.0 in Q4 2025.
  • Historically, Asset Writedowns and Impairment has averaged $132.8 billion across 5 years, with a median of $157541.0 in 2022.
  • Across the five-year window, Asset Writedowns and Impairment jumped 436751488.8% in 2023 and slumped 100.18% in 2024, its largest moves.
  • Year by year, Asset Writedowns and Impairment stood at $817875.0 in 2022, then surged by 162424231.35% to $1328.4 billion in 2023, then plunged by 100.0% to $155000.0 in 2024, then slumped by 454.19% to -$549000.0 in 2025, then jumped by 76.68% to -$128000.0 in 2026.
  • Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were -$128000.0 in Q1 2026, -$549000.0 in Q4 2025, and $155000.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -128,000.00
Mar 31, 2026 -128,000.00
Dec 31, 2025 -549,000.00
Dec 31, 2025 -549,000.00
Jun 30, 2024 155,000.00
Jun 30, 2024 155,000.00
Mar 31, 2024 -10,000.00
Mar 31, 2024 -10,000.00
Jun 30, 2023 1,328.43 Bn
Jun 30, 2023 1,328.43 Bn
Mar 31, 2023 5.53 Mn
Mar 31, 2023 5.53 Mn
Dec 31, 2022 817,875.00
Dec 31, 2022 817,875.00
Sep 30, 2022 160,082.00
Sep 30, 2022 160,082.00
Jun 30, 2022 304,161.00
Jun 30, 2022 304,161.00
Mar 31, 2022 80,110.00
Mar 31, 2022 80,110.00